Abstract Purpose of Review Although Glucagon-like peptide (GLP)-1 receptor agonists have
been used for almost two decades in the treatment of diabetes mellitus type 2 and, lately, in …

Parenteral nutrition (PN) is a life-saving therapy providing nutritional support in patients with
digestive tract complications, particularly in preterm neonates due to their gut immaturity …

Background Short bowel syndrome (SBS) is the main cause of intestinal failure in children.
Objectives This single-center study evaluated the safety and efficacy of teduglutide in …

Short bowel syndrome (SBS) is the leading cause of intestinal failure (IF) in children. The
preferred treatment for IF is parenteral nutrition which may be required until adulthood. The …

Summary Background and aims Home Parenteral Nutrition (HPN) is the cornerstone
management for children suffering from chronic intestinal failure (CIF). In France, HPN is …

The ability to deliver nutrients via parenteral nutrition (PN) has markedly improved the
prognosis of infants and children with intestinal failure. Technical refinements and advances …

Necrotizing enterocolitis (NEC), the first cause of short bowel syndrome (SBS) in the
neonate, is a serious neonatal gastrointestinal disease with an incidence of up to 11% in …

Background & Aims Diagnostic criteria, progression risk and optimal monitoring for intestinal
failure (IF)-associated liver disease (IFALD) remain undefined. We assessed predictors, non …

Background Disturbed bile acid homeostasis may foster development of short bowel
syndrome (SBS) associated liver disease during and after weaning off parenteral nutrition …

Background This analysis assessed combined safety data from 4 clinical studies of
teduglutide in pediatric patients with short‐bowel syndrome–associated intestinal failure …